Risk of stroke in patients with inflammatory bowel disease: a systematic review and meta-analysis

Chao Luo1, Lingpei Liu1, Di Zhu1

  • 1Department of General Practice, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua Municipal Central Hospital, Jinhua, Zhejiang, 321000, China.

BMC Gastroenterology
|February 25, 2025
PubMed

Insights

Inflammatory bowel disease (IBD) patients face a higher stroke risk. Crohn's disease (CD) poses a greater risk than ulcerative colitis (UC), underscoring the need for cardiovascular monitoring in IBD care.

Area of Science:

  • Gastroenterology
  • Cardiology
  • Epidemiology

Background:

  • Growing evidence links inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), with increased cardiovascular disease risk.
  • Stroke is a significant concern within this association, necessitating further investigation into IBD patient populations.

Purpose of the Study:

  • To systematically evaluate and quantify the risk of stroke in individuals diagnosed with IBD compared to the general population.
  • To differentiate stroke risk between Crohn's disease (CD) and ulcerative colitis (UC) subtypes within the broader IBD category.

Main Methods:

  • A comprehensive systematic literature search was conducted across major databases (PubMed, Embase, CENTRAL, Scopus, CINAHL) up to September 2023.
  • Meta-analysis using a random-effects model was employed to calculate pooled hazard ratios (HRs) and 95% confidence intervals (CIs) for stroke occurrence.
  • Subgroup analyses were performed for CD, UC, and overall IBD, with publication bias assessed using Begg's and Egger's tests.

Main Results:

  • The meta-analysis included 13 studies encompassing 2,802,955 participants.
  • IBD patients exhibited a significantly elevated stroke risk (HR: 1.30, 95% CI: 1.21-1.39).
  • Subgroup analyses revealed higher stroke risk for CD (HR: 1.35, 95% CI: 1.22-1.49) and UC (HR: 1.15, 95% CI: 1.09-1.22).

Conclusions:

  • Both IBD overall and specifically Crohn's disease are associated with a statistically significant increase in stroke risk.
  • These findings highlight the critical need for integrated cardiovascular risk assessment and proactive management strategies in the routine care of IBD patients.
Abstract

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...